Christian Wenger
Member of the Board of Directors
Pharmaceuticals
Xeltis.
Switzerland
Biography
Dr. Christian C. Wenger, Ph.D., Dr. iur., LL.M. has been General Counsel of NLS Pharma AG since May 30, 2017. He is a Partner of Wenger Vieli Belser since 1999 and serves as its Member of Executive Board. Dr. Wenger serves as the President of CTI Invest. He is a Founding Partner of Zurich law firm Wenger Vieli, specializing in corporate and commercial law, mergers and acquisitions and private equity transactions and corporate restructuring. Dr. Wenger joined in Wenger Vieli Belser in 1996. In 2005, he practiced at a law firm in Madrid. From 1991 to 1992, Dr. Wenger was at Lenz & Staehelin, Attorneys-at-law, Zurich. He serves as the Chairman of the Board of Equatis AG. Dr. Wenger has been the Chairman of Aevis Victoria SA since July 02, 2012. He serves as the Chairman of the Supervisory Board of Chemolio Management AG. He serves as the Chairman of the Board of Pavatex S.A. He served as the Chairman of Falcon Private Bank Ltd. from March 2017 to September 6, 2017. Dr. Wenger serves as a Board Member of Xeltis AG. He has been a Non-Executive Director of Peach Property Group (Deutschland) AG since 2007. Dr. Wenger serves as a Director of BrainsToVentures AG, Nybron Flooring International Corporation, Appartement-Haus Oberdorf AG, Instituto Biochimico Limitada, Häberli Obst- und Beerenzentrum AG, Heidelberger Druckmaschinen Schweiz AG, HIAG Holding, Metall Design AG, Primetime AG, Sigg Switzerland AG, Swipar AG, Symantec Switzerland, LatinVision Inc., Chemolio Holding AG and Bridge Co. Switzerland. He serves as a Member of the Advisory Board of Cross Equity Partners AG. Dr. Wenger serves as a Directors of B-To-V Partners AG and BridgeCo LLC. Dr. Wenger serves as a Director of Swiss Private Equity & Corporate Finance Association. He is a Board Member of the Swiss Association for Private Equity and Corporate Finance and the European Venture Capital Association. Dr. Wenger served as the Chairman of Peach Property Group AG until May 9, 2014. He served as Vice Chairman of Spice Private Equity AG and served as its Director since May 2006. Dr. Wenger served as the Vice-Chairman of APEN AG and served as its Non-Executive Director since May 2006.
Research Interest
Pharmaceuticals
